Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test becomes the only FDA approved companion diagnostic indicated to aid assessment of HER2 low-metastatic breast cancer ...

Roche is the recipient of the new approval, getting the go-ahead from the US regulator for its PATHWAY HER2 (4B5) test to detect HER2-ultralow status in metastatic breast cancer patients ...

For more information on results, access the full article here. FDA Moves to Include HER2-Ultralow Status in PATHWAY HER2 (4B5) Test The FDA has expanded the approval for the PATHWAY anti-HER2/neu (4B5 ...

Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions, today announced that it ...

SANTA FE — Three years after New Mexico began allowing the legal sale of cannabis, a bill giving a state agency authority to clamp down on illicit products is halfway to Gov. Michelle Lujan ...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central ...

SWEET7 is making big moves in Metro Vancouver, and this time, it's Richmond's turn to get in on the action. After debuting ...

State Key Laboratory of Supramolecular Structure and Materials, Center for Supramolecular Chemical Biology, College of Chemistry, Jilin University, Changchun 130012, P.R. China Joint Laboratory of ...

Journal of Nuclear Medicine February 2025, jnumed.124.269024; DOI: https://doi.org/10.2967/jnumed.124.269024 ...